Cephalosporins Should Not Be The Preferred Empiric Oral Antibiotics for Treatment of Outpatient Acute Pyelonephritis
Stick with TMP-SMX or a fluoroquinolone as your primary empiric oral choices for pyelonephritis unless local resistance patterns dictate otherwise. While cephalosporins are sometimes used, remember that empirical choice needs careful consideration of drug safety profiles and susceptibility data to ensure optimal coverage without unnecessary resistance pressure.
This article strongly cautions against using cephalosporins as the default empiric oral antibiotic choice for outpatient acute pyelonephritis, despite their increasing use in practice. It reiterates that TMP-SMX and fluoroquinolones remain the established first-line agents for managing this potentially serious infection outside the hospital setting. The authors emphasize that any empirical selection must be highly tailored, taking into account local antibiogram data, known drug toxicities, and individual patient comorbidities to guide therapy appropriately.